Cargando…
Characterisation of the main PSA glycoforms in aggressive prostate cancer
Serum levels of prostate specific antigen (PSA) are commonly used for prostate cancer (PCa) detection. However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers. Aberrant glycosyl...
Autores principales: | Gratacós-Mulleras, Anna, Duran, Adrià, Asadi Shehni, Akram, Ferrer-Batallé, Montserrat, Ramírez, Manel, Comet, Josep, de Llorens, Rafael, Saldova, Radka, Llop, Esther, Peracaula, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643140/ https://www.ncbi.nlm.nih.gov/pubmed/33149259 http://dx.doi.org/10.1038/s41598-020-75526-3 |
Ejemplares similares
-
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes
por: Llop, Esther, et al.
Publicado: (2016) -
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum
por: Llop, Esther, et al.
Publicado: (2018) -
Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection
por: Ferrer-Batallé, Montserrat, et al.
Publicado: (2017) -
Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera
por: Duran, Adrià, et al.
Publicado: (2022) -
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells
por: Greville, Gordon, et al.
Publicado: (2021)